The co-occurrence of multiple sclerosis and type 1 diabetes: Shared aetiologic features and clinical implication for MS aetiology

We reviewed the evidence for the co-occurrence of type 1 diabetes mellitus (T1D) and multiple sclerosis (MS), and assessed the clinical significance of this association and the shared aetiological features of the two diseases. T1D and MS contribute considerably to the burden of autoimmune diseases in young adults. The co-occurrence of MS and T1D has been reported by a number of studies, suggesting that the two conditions share one or more aetiological components. Both conditions have been associated with distinct human leukocyte antigen (HLA) haplotypes but share a number of similarities in clinical, epidemiological and immunological features, leading to suggestions of possible common mechanisms of development. While underlying genetic factors may be important for the co-occurrence of both conditions, some evidence suggests that environmental factors such as vitamin D deficiency may also modulate an individual's risk for the development of both conditions. Evidence on whether the co-occurrence of the two autoimmune conditions will affect the disease course and severity of MS is merely absent. Further studies need to be conducted to ascertain whether the neuropathology associated with T1D might influence the disease course and contribute to the severity of MS.

[1]  J. Haselkorn,et al.  Modifiable Comorbidities and Disability in Multiple Sclerosis , 2012, Current Neurology and Neuroscience Reports.

[2]  Z. Stelmasiak,et al.  [Multiple sclerosis and other autoimmune diseases]. , 2007, Neurologia i neurochirurgia polska.

[3]  J. Haines,et al.  The expanding genetic overlap between multiple sclerosis and type I diabetes , 2009, Genes and Immunity.

[4]  O. Abramsky,et al.  An association between multiple sclerosis and diabetes mellitus , 1992 .

[5]  Colin McKerlie,et al.  Type I Diabetes and Multiple Sclerosis Patients Target Islet Plus Central Nervous System Autoantigens; Nonimmunized Nonobese Diabetic Mice Can Develop Autoimmune Encephalitis1 , 2001, The Journal of Immunology.

[6]  Å. Lernmark.  Multiple sclerosis and type 1 diabetes: an unlikely alliance , 2002, The Lancet.

[7]  S. Romagnani.  Biology of human TH1 and TH2 cells , 1995, Journal of Clinical Immunology.

[8]  M. Ezzati,et al.  National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants , 2011, The Lancet.

[9]  A. Ascherio,et al.  Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. , 2006, JAMA.

[10]  Alireza Minagar,et al.  Blood-brain barrier disruption in multiple sclerosis , 2003, Multiple sclerosis.

[11]  Geert Jan Biessels,et al.  The effects of type 1 diabetes on cognitive performance: a meta-analysis. , 2005, Diabetes care.

[12]  Plamen Nikolov,et al.  Economic Costs of Diabetes in the U.S. in 2002 , 2003, Diabetes care.

[13]  W. Suarez-Pinzon,et al.  Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus. , 1998, Biochemical pharmacology.

[14]  E. Gale,et al.  Diabetes and gender , 2001, Diabetologia.

[15]  M. Calabrese,et al.  Multiple sclerosis and autoimmune diseases , 2006, Journal of Neurology.

[16]  T. Hudson,et al.  Toward Further Mapping of the Association Between the IL2RA Locus and Type 1 Diabetes , 2007, Diabetes.

[17]  R. Marrie,et al.  Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis , 2010, Neurology.

[18]  J. Aarseth,et al.  A 50-year follow-up of the incidence of multiple sclerosis in Hordaland County, Norway , 2006, Neurology.

[19]  A. Ascherio,et al.  Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors , 2007, Annals of neurology.

[20]  A. Akobeng,et al.  Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis , 2008, Archives of Disease in Childhood.

[21]  G. Sechi,et al.  Prevalence and 4-year incidence of insulin-dependent diabetes mellitus in the province of Oristano (Sardinia, Italy) , 1997, Acta Diabetologica.

[22]  H. Gerstein.  Cow's Milk Exposure and Type I Diabetes Mellitus: A critical overview of the clinical literature , 1994, Diabetes Care.

[23]  J. Ilonen,et al.  Humoral beta-cell autoimmunity in relation to HLA-defined disease susceptibility in preclinical and clinical type 1 diabetes. , 2002, American journal of medical genetics.

[24]  J. Hillebrands,et al.  Viral infections as potential triggers of type 1 diabetes , 2007, Diabetes/metabolism research and reviews.

[25]  J. M. Burton,et al.  A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis , 2010, Neurology.

[26]  S. Azar,et al.  T Helper Type 1 and 2 Cytokines Mediate the Onset and Progression of Type I (Insulin-Dependent) Diabetes , 1999 .

[27]  G. Giovannoni,et al.  Smoking and Multiple Sclerosis: An Updated Meta-Analysis , 2011, PloS one.

[28]  Alireza Minagar,et al.  Multiple sclerosis as a vascular disease , 2006, Neurological research.

[29]  J. Tuomilehto,et al.  Incidence and trends of childhood Type 1 diabetes worldwide 1990–1999 , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[30]  G. Giovannoni,et al.  Autoimmune disease in people with multiple sclerosis and their relatives: a systematic review and meta-analysis , 2013, Journal of Neurology.

[31]  P. Contu,et al.  Patients with multiple sclerosis and risk of type 1 diabetes mellitus in Sardinia, Italy: a cohort study , 2002, The Lancet.

[32]  S. Mellgren,et al.  Effect of vitamin D3 supplementation on relapses, disease progression, and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial , 2012, Multiple sclerosis.

[33]  A. Avenell,et al.  Systematic Review and Meta-Analysis of the Sero-Epidemiological Association between Epstein Barr Virus and Multiple Sclerosis , 2013, PloS one.

[34]  Robyn M Lucas,et al.  Estimating the global disease burden due to ultraviolet radiation exposure. , 2008, International journal of epidemiology.

[35]  Björn Eliasson,et al.  Cigarette smoking and diabetes. , 2003, Progress in cardiovascular diseases.

[36]  A. Carlsson,et al.  Time trends and gender differences in incidence and prevalence of type 1 diabetes in Sweden. , 2013, Current diabetes reviews.

[37]  S. Kikuchi,et al.  Increasing prevalence and incidence of multiple sclerosis in northern Japan , 2008, Multiple sclerosis.

[38]  S. Mohr,et al.  The association between ultraviolet B irradiance, vitamin D status and incidence rates of type 1 diabetes in 51 regions worldwide , 2008, Diabetologia.

[39]  Robert D. Henderson,et al.  The occurrence of autoimmune diseases in patients with multiple sclerosis and their families , 2000, Journal of Clinical Neuroscience.

[40]  L. Blizzard,et al.  Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis , 2011, Journal of Neurology, Neurosurgery & Psychiatry.

[41]  M. Melbye,et al.  Type 1 diabetes and multiple sclerosis: A Danish population-based cohort study. , 2006, Archives of neurology.

[42]  F. Guillemin,et al.  Increasing incidence of multiple sclerosis among women in Lorraine, Eastern France , 2007, Multiple sclerosis.

[43]  S. Azar,et al.  Clinical review 103: T helper type 1 and 2 cytokines mediate the onset and progression of type I (insulin-dependent) diabetes. , 1999, The Journal of clinical endocrinology and metabolism.

[44]  T. Wilsgaard,et al.  Outdoor activities and diet in childhood and adolescence relate to MS risk above the Arctic Circle , 2007, Journal of Neurology.

[45]  C. Tench,et al.  Tobacco smoking and disability progression in multiple sclerosis: United Kingdom cohort study , 2013, Brain : a journal of neurology.

[46]  T. Dwyer,et al.  Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study , 2003, BMJ : British Medical Journal.

[47]  E. Mowry,et al.  Vitamin D status is associated with relapse rate in pediatric‐onset multiple sclerosis , 2010, Annals of neurology.

[48]  J. Todd,et al.  Clustering of autoimmune disease in parents of siblings from the Type 1 diabetes Warren repository , 2004, Diabetic medicine : a journal of the British Diabetic Association.

[49]  M. Atkinson,et al.  Type 1 diabetes: new perspectives on disease pathogenesis and treatment , 2001, The Lancet.

[50]  M. Songini,et al.  Type 1 diabetes and multiple sclerosis: together at last. , 2003, Diabetes care.

[51]  Elina Hyppönen,et al.  Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study , 2001, The Lancet.

[52]  T. Dwyer,et al.  Higher 25‐hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis , 2010, Annals of neurology.

[53]  TCRBV20S1 polymorphism does not influence the susceptibility to type 1 diabetes and multiple sclerosis in the Sardinian population , 2012, Immunogenetics.

[54]  M. V. von Herrath,et al.  Virus infections in type 1 diabetes. , 2012, Cold Spring Harbor perspectives in medicine.

[55]  S. Hauser,et al.  Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: A case for antigen‐specific antibody mediation , 1999, Annals of neurology.

[56]  A. Ponsonby,et al.  Ecologic analysis of some immune-related disorders, including type 1 diabetes, in Australia: latitude, regional ultraviolet radiation, and disease prevalence. , 2003, Environmental health perspectives.

[57]  P. Sørensen,et al.  The changing demographic pattern of multiple sclerosis epidemiology , 2010, The Lancet Neurology.

[58]  Jaakko Tuomilehto,et al.  Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study , 2008, The Lancet.

[59]  C. Beaufort.  Variation and trends in incidence of childhood diabetes in Europe , 2000, The Lancet.

[60]  M. Knip,et al.  Putative environmental factors in Type 1 diabetes. , 1998, Diabetes/metabolism reviews.

[61]  A. Ponsonby,et al.  UVR, Vitamin D and Three Autoimmune Diseases—Multiple Sclerosis, Type 1 Diabetes, Rheumatoid Arthritis , 2005, Photochemistry and photobiology.

[62]  J. Salzer.  Environmental risk factors for multiple sclerosis , 2013 .

[63]  A. Compston,et al.  Multiple sclerosis. , 2002, Lancet.

[64]  L. Svenson,et al.  Contribution of incidence to increasing prevalence of multiple sclerosis in Alberta, Canada , 2008, Multiple sclerosis.

[65]  L. Kuller,et al.  Menopause in type 1 diabetic women: is it premature? , 2001, Diabetes.

[66]  R. Bloigu,et al.  Increasing incidence of multiple sclerosis in women in Northern Finland , 2011, Multiple sclerosis.

[67]  Elizabeth R Seaquist,et al.  Cognitive Dysfunction and Diabetes Mellitus , 2022 .

[68]  G. Ebers,et al.  Relationship of UV exposure to prevalence of multiple sclerosis in England , 2011, Neurology.

[69]  M. Hernán,et al.  Temporal trends in the incidence of multiple sclerosis , 2008, Neurology.

[70]  T. Riise,et al.  Incidence of multiple sclerosis in Møre and Romsdal, Norway from 1950 to 1991. An age-period-cohort analysis. , 1996, Brain : a journal of neurology.

[71]  L. Massacesi,et al.  Multiple sclerosis and Type I diabetes , 2002, Diabetologia.

[72]  L. Wald,et al.  Association of UV radiation with multiple sclerosis prevalence and sex ratio in France , 2011, Neurology.

[73]  T. Riise,et al.  Increasing Incidence of Multiple Sclerosis in the Province of Sassari, Northern Sardinia , 2005, Neuroepidemiology.

[74]  H. D. de Melker,et al.  Incidence of Multiple Sclerosis in the General Population in the Netherlands, 1996–2008 , 2012, Neuroepidemiology.

[75]  A. Tselis.  Epstein–Barr virus cause of multiple sclerosis , 2012, Current opinion in rheumatology.

[76]  I. Mackay,et al.  Multiple sclerosis and autoimmune diseases. , 1972, Australian and New Zealand journal of medicine.

[77]  H. Mcdevitt,et al.  Insulin-dependent diabetes mellitus: the initial lesion. , 1981, The New England journal of medicine.

[78]  L. Grimaldi,et al.  High Prevalence and Fast Rising Incidence of Multiple Sclerosis in Caltanissetta, Sicily, Southern Italy , 2006, Neuroepidemiology.

[79]  D. B. Williams,et al.  Progressive increase in incidence and prevalence of multiple sclerosis in Newcastle, Australia: a 35-year study , 2003, Journal of the Neurological Sciences.

[80]  M. Hernán,et al.  Geographic variation of MS incidence in two prospective studies of US women , 1999, Neurology.

[81]  P. Hogan,et al.  Economic Costs of Diabetes in the U , 2013 .

[82]  Chung-Yi Li,et al.  Incidence of and Mortality from Type I Diabetes in Taiwan From 1999 through 2010: A Nationwide Cohort Study , 2014, PloS one.

[83]  W. Willett,et al.  Vitamin D intake and incidence of multiple sclerosis , 2004, Neurology.

[84]  K. Lauer.  Diet and multiple sclerosis , 1997, Neurology.

[85]  W. Hussein,et al.  Prevalence of Diabetes in Patients With Multiple Sclerosis , 2006, Diabetes Care.

[86]  O. Abramsky,et al.  An association between multiple sclerosis and type I diabetes mellitus , 2004, Journal of Neurology.

[87]  C. Levy-marchal,et al.  The growing incidence of type 1 diabetes in children: the 17-year French experience in Aquitaine. , 2008, Diabetes & metabolism.

[88]  M. Filippi,et al.  A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[89]  D. Selvarajah,et al.  Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy , 2012, Diabetes/metabolism research and reviews.

[90]  M. Gomes,et al.  Impact of Diabetes on Cardiovascular Disease: An Update , 2013, International journal of hypertension.

[91]  A. Blaschek,et al.  Higher Relative Risk for Multiple Sclerosis in a Pediatric and Adolescent Diabetic Population: Analysis From DPV Database , 2013, Diabetes Care.